netFormulary Dorset NHS
The Dorset Formulary has been developed in associations with
NHS Dorset Clinical Commissioning Group
Dorset County Hospital NHS Foundation Trust
Dorset Healthcare University NHS Foundation Trust
Poole Hospital NHS Foundation Trust
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust		  
 Search
 Formulary Chapter 5: Infections - Full Chapter
Notes:

Chapter review date:
Chapter Links...
Link   SCAN Guidelines for antibiotic prescribing in the community 2018
Link   NICE NG19: Diabetic foot problems: prevention and management (October 2019)
Link   NICE NG138: Pneumonia (community-acquired): antimicrobial prescribing (September 2019)
Link   NICE NG139: Pneumonia (hospital-acquired): antimicrobial prescribing (September 2019)
Link   NICE NG141: Cellulitis and erysipelas: antimicrobial prescribing (September 2019)
Link   NICE NG120: Cough (acute): antimicrobial prescribing (February 2019)
Link   NICE NG114: Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing (December 2018)
Link   NICE NG117: Bronchiectasis (acute exacerbation): antimicrobial prescribing (December 2018)
Link   NICE NG112: Urinary tract infection (recurrent): antimicrobial prescribing (October 2018)
Link   NICE NG110: Prostatitis (acute): antimicrobial prescribing (October 2018)
Link   NICE NG111: Pyelonephritis (acute): antimicrobial prescribing (October 2018)
Link   NICE NG109: Urinary tract infection (lower): antimicrobial prescribing (October 2018)
Link   NICE NG95: Lyme Disease (April 2018)
Link   NICE NG91 Otitis media (acute): antimicrobial prescribing (March 2018)
Link   NICE NG84 Sore throat (acute): antimicrobial prescribing (January 2018)
Link   NICE NG79 Sinusitis (acute): antimicrobial prescribing (October 2017)
Link   BHIVA Guidelines
Link   Dental Letter Infective Endocarditis March 2019
Link   Dorset Guidance:Antibiotic Prophylaxis (AP) prior to Dental Treatment to prevent Infective Endocarditis March 2019
Link   SDCEP Antibiotic Prophylaxis Against Infective Endocarditis
Link   DCHFT: Adult Surgical Antibiotic Treatment Guidelines
Link   DCHFT: IV antibiotic to oral switch guidelines
Link   DCHFT: Medical Directorate Antibiotic Treatment Guidelines
Link   DCHFT: Antibiotic stop / review date and indication policy
Link   DCHFT: Penicillin allergy ’traffic light’ guideline
 Details...
05.03.04  Expand sub section  Influenza
Oseltamivir (Tamiflu®)
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Green

03/12/2019 - Surveillance data indicates an increase in influenza cases in the community. Prescribers may now prescribe and pharmacists may now supply antiviral medicines for the prophylaxis and treatment of influenza at NHS expense (FP10). Please see here for more information

For influenza prophylaxis in accordance with NICE TA158 and NICE TA168. 

(03/12/2019 - now in season. Do not use FLUOOS) For the treatment of influenza out of flu season, please search the term "fluoos" in the search bar and follow the guidance provided.  

For the treatment of influenza in adults and children if all the following circumstances apply:

•national surveillance schemes indicate that influenza virus A or B is circulating
•the person is in an 'at-risk' group as defined in the guidance
•the person presents with an influenza-like illness and can start treatment within 48 hours (or within 36 hours for zanamivir treatment in children) of the onset of symptoms as per licensed indications.

Vaccination, particularly targeting "high risk" patients, remains the mainstay of influenza management.

 
Link  03/12/2019 - Flu season has begun
Link  NICE TA158. oseltamavir, amantadine (review) and zanamavir for the prophylaxis of influenza
Link  NICE TA168 Amantadine, oseltamivir and zanamivir for the treatment of influenza
   
Zanamivir dry powder for inhalation (Relenza®)
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Green

03/12/2019 - Surveillance data indicates an increase in influenza cases in the community. Prescribers may now prescribe and pharmacists may now supply antiviral medicines for the prophylaxis and treatment of influenza at NHS expense (FP10). Please see here for more information

For influenza prophylaxis and treatment in accordance with NICE recommendations (TAs 158 and 168).

For the treatment of influenza in adults and children if all the following circumstances apply:

•national surveillance schemes indicate that influenza virus A or B is circulating
•the person is in an 'at-risk' group as defined in the guidance
•the person presents with an influenza-like illness and can start treatment within 48 hours (or within 36 hours for zanamivir treatment in children) of the onset of symptoms as per licensed indications.


Vaccination particularly targeting 'high risk' patients remains the mainstay of influenza management.

 
Link  03/12/2019 - Flu season has begun
Link  NICE TA 158: oseltamavir, amantadine (review) and zanamavir for the prophylaxis of influenza
Link  NICE TA 168: amantadine, oseltamavir and zanamavir for the treatment of influenza
   
Zanamivir Injection (Dectova)
 Track Changes 		Restricted Drug Restricted
Red

For use in line with PHE Influenza guidelines 

 
   
 link Link    2019 PHE guidance on the use of antiviral agents for the treatment and prophylaxis of seasonal influenza
 link Link    Community Pharmacy Claim Form for fluOOS
 link Link    FluOOS Invoice Template
 link Link    FluOOS PSD (Patient Specific Direction)
 link Link    NICE TA158: Influenza prophylaxis (NICE 2008)
 link Link    NICE TA168: Influenza treatment - zanamivir, amantadine and oseltamivir
 link Link    Out of Season Influenza Prescribing Protocol (fluOOS)
 link Link    UKMI Q&A: Breastfeeding after treatment with oseltamivir or zanamivir?
 ....
 Non Formulary Items
Amantadine Hydrochloride  (Lysovir®)

View adult BNF View SPC online View childrens BNF 		Non Formulary
Black

Not recommended for prophylaxis in line with NICE TA 158.
Link  NICE TA158 Amantadine, oseltamivir and zanamivir for the treatment of influenza
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to children's BNF
click to search medicines.org.uk
 Link to SPCs
Cytotoxic Drug
 Cytotoxic Drug
CD
 Controlled Drug
High Cost Medicine
 High Cost Medicine
Cancer Drugs Fund
 Cancer Drugs Fund
NHSE
 NHS England
Homecare
 Homecare
CCG
 CCG

Traffic Light Status Information

Status Description

Green

 May be initiated, stabilised and maintained in primary, secondary or tertiary care  

Amber

 Amber drug - without shared care  

Amber SCG

 Amber drug - with shared care guideline  

Red

 For secondary or tertiary care initiation and long-term maintenance of prescribing  

Black

 Not recommended  

netFormulary